骨がん治療の世界市場レポート 2025年

骨がん治療の市場規模は、今後数年間で力強い成長が見込まれます。2029年には17億3,000万米ドルに成長し、CAGRは5.9%となります。予測期間の成長は、ヘルスケア政策の変化、患者中心のケアモデルへのシフト、遠隔医療と遠隔モニタリングの拡大、がん患者の増加、効果的な治療法の利用不能、副作用などに起因すると考えられます。予測期間における主な動向としては、骨がん啓発のための政府の取り組み、ヘルスケア機器の技術進歩、研究開発活動の増加、遺伝子編集技術の探求と開発、学界、製薬会社、ヘルスケア機関の協力関係の強化などが挙げられます。

骨がんの有病率の増加は、骨がん治療市場の拡大を促進すると予測されています。骨がんは、骨組織から発生する悪性腫瘍の一群で構成され、骨における制御不能な細胞分裂と増殖の結果として生じる。骨がんの治療戦略は、外科的介入、四肢の温存、疼痛緩和、QOLの改善、効果的な腫瘍管理など、患者にいくつかの利点を提供することを目的としています。2023年2月の米国臨床腫瘍学会（ASCO）の報告によると、米国では推定3,970例の原発性骨肉腫が新たに診断されると予想され、その内訳は男性が2,160例、女性が1,810例で、15歳から19歳の患者における2013年の400例からの増加を反映しています。このように、骨がんの有病率の増加は骨がん治療市場の原動力となっています。

骨がん治療市場の成長は、老人人口の増加によってさらに促進されると予想されます。老人人口」とは、65歳以上の個人を指します。骨がん治療は、長骨の骨細胞から発生することが多く、その発生率は加齢とともに増加する傾向があるため、この層には不可欠です。高齢者特有のニーズに対応し、治療成績を向上させるために、高度な治療オプションが利用可能です。世界保健機関（WHO）によると、世界全体では2030年までに6人に1人が60歳以上になり、この年齢層は2050年までに21億人に倍増すると予測されています。英国では、下院図書館が2021年6月に報告したところによると、2043年までに高齢者人口は総人口の24％を占め、1,740万人に達すると予想されています。従って、老人人口の増加は骨がん治療市場の成長促進要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の骨がん治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の骨がん治療市場：成長率分析
• 世界の骨がん治療市場の実績：規模と成長, 2019-2024
• 世界の骨がん治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界の骨がん治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の骨がん治療市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 多発性骨髄腫
• 骨肉腫
• 軟骨肉腫
• ユーイング肉腫
• 世界の骨がん治療市場：治療タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 化学療法
• 標的療法
• 放射線治療
• 手術
• その他の治療の種類
• 世界の骨がん治療市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• ドラッグストアと小売薬局
• オンライン薬局
• 世界の骨がん治療市場、タイプ別サブセグメンテーション：多発性骨髄腫、実績と予測, 2019-2024, 2024-2029F, 2034F
• 化学療法
• 免疫療法
• 標的療法
• 幹細胞移植
• 世界の骨がん治療市場、タイプ別サブセグメンテーション：骨肉腫、実績と予測, 2019-2024, 2024-2029F, 2034F
• 外科的切除
• 化学療法
• 放射線治療
• 標的療法
• 世界の骨がん治療市場、タイプ別サブセグメンテーション：軟骨肉腫、実績と予測, 2019-2024, 2024-2029F, 2034F
• 外科的切除
• 化学療法
• 放射線治療
• 世界の骨がん治療市場、タイプ別サブセグメンテーション：ユーイング肉腫、実績と予測, 2019-2024, 2024-2029F, 2034F
• 化学療法
• 外科的切除
• 放射線治療
• 標的療法

第7章 地域別・国別分析

• 世界の骨がん治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の骨がん治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 骨がん治療市場：競合情勢
• 骨がん治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Novartis AG
• Sanofi S.A.
• Bristol-Myers Squibb Company
• AstraZeneca plc
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Boehringer Ingelheim International GmbH
• Amgen Inc.
• Otsuka Pharmaceutical Co. Ltd.
• Astellas Pharma Inc.
• Eisai Co. Ltd.
• Jazz Pharmaceuticals plc
• Incyte Corporation
• Ipsen SA

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 骨がん治療市場2029：新たな機会を提供する国
• 骨がん治療市場2029：新たな機会を提供するセグメント
• 骨がん治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

The term 'bone cancer treatment' encompasses the methodologies employed to address and combat bone cancer, a form of cancer originating in bone tissue. This treatment is applied to both primary bone cancers, originating within the bone, and secondary bone cancers, which initiate in another part of the body and subsequently spread to the bone.

The principal categories of bone cancer treatment include multiple myeloma, osteosarcoma, chondrosarcoma, and Ewing sarcoma. Multiple myeloma is a cancer affecting plasma cells, a subtype of white blood cells responsible for antibody production. Treatment modalities for multiple myeloma encompass various approaches such as chemotherapy, targeted therapy, radiation therapy, surgery, and others. The distribution channels for these treatments include hospital pharmacies, drug stores and retail pharmacies, as well as online pharmacies.

The bone cancer treatment market research report is one of a series of new reports from The Business Research Company that provides bone cancer treatment market statistics, including bone cancer treatment industry global market size, regional shares, competitors with a bone cancer treatment market share, detailed bone cancer treatment market segments, market trends and opportunities, and any further data you may need to thrive in the bone cancer treatment industry. This bone cancer treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The bone cancer treatment market size has grown strongly in recent years. It will grow from $1.3 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to evolution of imaging technologies, refinement of biopsy techniques, discovery and advancement in pharmaceuticals, improvements in healthcare infrastructure, advancements in supportive care

The bone cancer treatment market size is expected to see strong growth in the next few years. It will grow to $1.73 billion in 2029 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to changes in healthcare policies, shift towards patient-centric care models, expansion of telemedicine and remote monitoring, increasing number of cancer patients, unavailability of effective treatment and side effects. Major trends in the forecast period include government initiatives for bone cancer awareness, technological advancements in healthcare devices, increasing research and development activities, exploration and development of gene-editing techniques, increased collaboration between academia, pharmaceutical companies, and healthcare institutions.

The increasing prevalence of bone cancer is anticipated to fuel the expansion of the bone cancer treatment market. Bone cancer comprises a group of malignant tumors that originate in bone tissue, resulting from uncontrolled cell division and growth in the bone. Treatment strategies for bone cancer aim to provide several advantages to patients, encompassing surgical interventions, limb preservation, pain relief, improved quality of life, and effective tumor management. As per reports from the American Society of Clinical Oncology (ASCO) in February 2023, an estimated 3,970 new cases of primary bone sarcoma are expected to be diagnosed in the US, with 2,160 in men and 1,810 in women, reflecting an increase from 400 cases in 2013 among individuals aged 15 to 19. Thus, the increasing prevalence of bone cancer acts as a driving force for the bone cancer treatment market.

The growth of the bone cancer treatment market is further expected to be propelled by the rise in the geriatric population. The term 'geriatric population' refers to individuals aged 65 years and older. Bone cancer treatment is essential for this demographic as the disease often originates in the bone cells of long bones, and its incidence tends to increase with age. Advanced treatment options are available to address the specific needs of older adults and enhance treatment outcomes. According to the World Health Organization, globally, by 2030, 1 in 6 people will be 60 or older, and this age group is projected to double to 2.1 billion by 2050. In the UK, the House of Commons Library reported in June 2021 that by 2043, the senior population is expected to constitute 24% of the total population, reaching 17.4 million people. Hence, the rise in the geriatric population serves as a driving factor for the growth of the bone cancer treatment market.

Major companies in the bone cancer treatment market are concentrating on the introduction of immunotherapy to deliver targeted therapies that leverage the body's immune system to more effectively combat cancer. Immunotherapy is a type of cancer treatment that utilizes the immune system to attack cancer cells. For example, in July 2023, MedPacto, a drug developer based in South Korea, received orphan drug designation from the European Medicines Agency (EMA) for its drug vactosertib, intended for the treatment of osteosarcoma. Vactosertib specifically targets and inhibits the TGF-beta (transforming growth factor-beta) signaling pathway, which is associated with tumor progression and metastasis. The orphan drug designation for vactosertib marks a significant advancement in the development of new therapies for osteosarcoma, providing hope for enhanced treatment options for patients suffering from this rare and aggressive form of bone cancer.

Major players in the bone cancer treatment market are actively introducing next-generation drugs, including prescription medicines, to gain a competitive advantage. Prescription medicines are pharmaceutical drugs that can only be legally obtained with a written order from a qualified healthcare professional, such as a doctor or dentist. For instance, in September 2023, GSK plc, a UK-based pharmaceutical and biotechnology company, launched Ojjaara (Momelotinib), a prescription medicine designed to treat certain types of myelofibrosis (MF) in adults. Myelofibrosis is a rare form of bone marrow cancer that disrupts the normal production of blood cells. Ojjaara (Momelotinib) offers a novel and effective treatment option for patients grappling with bone cancer and anemia.

In July 2022, GSK plc, a pharmaceutical company based in the UK, acquired Sierra Oncology for $1.9 billion. This acquisition strengthens GSK's ability to treat bone cancer, particularly with the addition of momelotinib, a drug specifically designed for patients with myelofibrosis. Sierra Oncology Inc. is a biotechnology company located in the US that specializes in targeted therapies for bone cancer treatment.

Major companies operating in the bone cancer treatment market include Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Otsuka Pharmaceutical Co. Ltd., Astellas Pharma Inc., Eisai Co. Ltd., Jazz Pharmaceuticals plc, Incyte Corporation, Ipsen SA, Kyowa Hakko Kirin Co. Ltd., Seagen Inc., Exelixis Inc., BeiGene Ltd., Daiichi Sankyo Company Limited, Karyopharm Therapeutics.

North America was the largest region in the bone cancer treatment market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the bone cancer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the bone cancer treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The bone cancer treatment market includes revenues earned by entities by providing diagnosis and staging, supportive care, multidisciplinary care, biopsy, pain management, and psychosocial support services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bone Cancer Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bone cancer treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bone cancer treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bone cancer treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Multiple Myeloma; Osteosarcoma; Chondrosarcoma; Ewing Sarcoma
• 2) By Treatment Type: Chemotherapy; Targeted Therapy; Radiation Therapy; Surgery; Other Treatment Types
• 3) By Distribution Channel: Hospital Pharmacies; Drug Store And Retail Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Multiple Myeloma: Chemotherapy; Immunotherapy; Targeted Therapy; Stem Cell Transplant
• 2) By Osteosarcoma: Surgical Resection; Chemotherapy; Radiation Therapy; Targeted Therapy
• 3) By Chondrosarcoma: Surgical Resection; Chemotherapy; Radiation Therapy
• 4) By Ewing Sarcoma: Chemotherapy; Surgical Resection; Radiation Therapy; Targeted Therapy
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bone Cancer Treatment Market Characteristics

3. Bone Cancer Treatment Market Trends And Strategies

4. Bone Cancer Treatment Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Bone Cancer Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Bone Cancer Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Bone Cancer Treatment Market Growth Rate Analysis
• 5.4. Global Bone Cancer Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Bone Cancer Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Bone Cancer Treatment Total Addressable Market (TAM)

6. Bone Cancer Treatment Market Segmentation

• 6.1. Global Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Multiple Myeloma
• Osteosarcoma
• Chondrosarcoma
• Ewing Sarcoma
• 6.2. Global Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemotherapy
• Targeted Therapy
• Radiation Therapy
• Surgery
• Other Treatment Types
• 6.3. Global Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Drug Store And Retail Pharmacies
• Online Pharmacies
• 6.4. Global Bone Cancer Treatment Market, Sub-Segmentation Of Multiple Myeloma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemotherapy
• Immunotherapy
• Targeted Therapy
• Stem Cell Transplant
• 6.5. Global Bone Cancer Treatment Market, Sub-Segmentation Of Osteosarcoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Surgical Resection
• Chemotherapy
• Radiation Therapy
• Targeted Therapy
• 6.6. Global Bone Cancer Treatment Market, Sub-Segmentation Of Chondrosarcoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Surgical Resection
• Chemotherapy
• Radiation Therapy
• 6.7. Global Bone Cancer Treatment Market, Sub-Segmentation Of Ewing Sarcoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemotherapy
• Surgical Resection
• Radiation Therapy
• Targeted Therapy

7. Bone Cancer Treatment Market Regional And Country Analysis

• 7.1. Global Bone Cancer Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Bone Cancer Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bone Cancer Treatment Market

• 8.1. Asia-Pacific Bone Cancer Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bone Cancer Treatment Market

• 9.1. China Bone Cancer Treatment Market Overview
• 9.2. China Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bone Cancer Treatment Market

• 10.1. India Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bone Cancer Treatment Market

• 11.1. Japan Bone Cancer Treatment Market Overview
• 11.2. Japan Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bone Cancer Treatment Market

• 12.1. Australia Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bone Cancer Treatment Market

• 13.1. Indonesia Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bone Cancer Treatment Market

• 14.1. South Korea Bone Cancer Treatment Market Overview
• 14.2. South Korea Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bone Cancer Treatment Market

• 15.1. Western Europe Bone Cancer Treatment Market Overview
• 15.2. Western Europe Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bone Cancer Treatment Market

• 16.1. UK Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bone Cancer Treatment Market

• 17.1. Germany Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bone Cancer Treatment Market

• 18.1. France Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bone Cancer Treatment Market

• 19.1. Italy Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bone Cancer Treatment Market

• 20.1. Spain Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bone Cancer Treatment Market

• 21.1. Eastern Europe Bone Cancer Treatment Market Overview
• 21.2. Eastern Europe Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bone Cancer Treatment Market

• 22.1. Russia Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bone Cancer Treatment Market

• 23.1. North America Bone Cancer Treatment Market Overview
• 23.2. North America Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bone Cancer Treatment Market

• 24.1. USA Bone Cancer Treatment Market Overview
• 24.2. USA Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bone Cancer Treatment Market

• 25.1. Canada Bone Cancer Treatment Market Overview
• 25.2. Canada Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bone Cancer Treatment Market

• 26.1. South America Bone Cancer Treatment Market Overview
• 26.2. South America Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bone Cancer Treatment Market

• 27.1. Brazil Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bone Cancer Treatment Market

• 28.1. Middle East Bone Cancer Treatment Market Overview
• 28.2. Middle East Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bone Cancer Treatment Market

• 29.1. Africa Bone Cancer Treatment Market Overview
• 29.2. Africa Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bone Cancer Treatment Market Competitive Landscape And Company Profiles

• 30.1. Bone Cancer Treatment Market Competitive Landscape
• 30.2. Bone Cancer Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Bone Cancer Treatment Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Sanofi S.A.
• 31.3. Bristol-Myers Squibb Company
• 31.4. AstraZeneca plc
• 31.5. GlaxoSmithKline plc
• 31.6. Takeda Pharmaceutical Company Limited
• 31.7. Eli Lilly and Company
• 31.8. Boehringer Ingelheim International GmbH
• 31.9. Amgen Inc.
• 31.10. Otsuka Pharmaceutical Co. Ltd.
• 31.11. Astellas Pharma Inc.
• 31.12. Eisai Co. Ltd.
• 31.13. Jazz Pharmaceuticals plc
• 31.14. Incyte Corporation
• 31.15. Ipsen SA

32. Global Bone Cancer Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bone Cancer Treatment Market

34. Recent Developments In The Bone Cancer Treatment Market

35. Bone Cancer Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Bone Cancer Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Bone Cancer Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Bone Cancer Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer